All Releases
 |
BioForm Medical Announces Extension of Lock-Up Period
May 5, 2008
|
8.8 KB |
|
| |
SAN MATEO, Calif., May 5, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced today that lock-up agreements entered into with its underwriters in conjunction with its initial public offering will be extended 18 days beyond the Company's May 1, 2008 earnings release. The lock-up period was due to exp...
|
|
BioForm Announces Financial Results for Quarter Ended March 31, 2008, Third Quarter of Fiscal 2008
May 1, 2008
|
16.5 KB |
|
| |
SAN MATEO, Calif., May 1, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced its financial results for the quarter ended March 31, 2008, which is the Company's third quarter of fiscal year 2008. Net sales were $17.0 million for the quarter ended March 31, 2008 as compared to $12.4 million for...
|
|
BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology
Apr 30, 2008
|
13.1 KB |
|
| |
SAN MATEO, Calif., April 30, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced that it has acquired substantially all of the assets of privately-held, Denver, CO based, Advanced Cosmetic Intervention, Inc. (ACI) and associated technology rights for $12 million cash, plus future royalties and a pot...
|
|
BioForm Medical to Announce Financial Results For Quarter Ended March 31, 2008, Third Quarter of Fiscal 2008, and Host Conference Call and Webcast on May 1, 2008
Apr 10, 2008
|
9.2 KB |
|
| |
SAN MATEO, Calif., April 10, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced that on Thursday, May 1, 2008, it will report its financial results for the quarter ended March 31, 2008, which is its third quarter fiscal year 2008. The Company will issue the earnings press release after the NASDAQ G...
|
|
BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008
Jan 31, 2008
|
15.4 KB |
|
| |
SAN MATEO, Calif., Jan 31, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced its financial results for the quarter ended December 31, 2007, which is the Company's second quarter of fiscal year 2008. Net sales were $18.6 million for the quarter ended December 31, 2007 as compared to $11.8 mil...
|
|
BioForm Medical to Announce Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008, and Host Conference Call and Webcast on January 31, 2008
Jan 16, 2008
|
9.2 KB |
|
| |
SAN MATEO, Calif., Jan 16, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced that on Thursday, January 31, 2008, it will report it financial results for the quarter ended December 31, 2007, which is its second quarter fiscal year 2008. The Company will issue the earnings press release after the NA...
|
|
RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial
Jan 14, 2008
|
12.4 KB |
|
| |
SAN MATEO, Calif., Jan 14, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced the publication of a post-marketing multi- center, randomized, blinded comparative study of nasolabial fold treatments reporting that RADIESSE(R) dermal filler was found to be significantly more effective than Resty...
|
|
BioForm Medical to Present at the 2008 JPMorgan Healthcare Conference on January 7, 2008
Dec 19, 2007
|
9.7 KB |
|
| |
SAN MATEO, Calif., Dec 19, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced that Steven Basta, Chief Executive Officer, will present a company overview at the upcoming 26th Annual JPMorgan Healthcare Conference being held from January 7-10, 2008. BioForm Medical's presentation will take pla...
|
|
BioForm Announces Financial Results for Quarter Ended September 30, 2007, First Quarter of Fiscal 2008
Dec 13, 2007
|
15.7 KB |
|
| |
SAN MATEO, Calif., Dec 13, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced its financial results for the quarter ended September 30, 2007, which is the Company's first quarter of fiscal year 2008. Net sales were $15.2 million for the quarter ended September 30, 2007 as compared to $7.8 mil...
|
|
Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
Dec 12, 2007
|
16.0 KB |
|
| |
SAN MATEO, Calif., Dec 12, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced the publication of a multi-center, randomized, blinded comparative study of nasolabial fold treatments reporting higher patient satisfaction with its Radiesse(R) dermal filler than reported after treatment with eith...
|
|
BioForm to Announce First Quarter Fiscal 2008 Financial Results and Host Conference Call and Webcast on December 13, 2007
Dec 5, 2007
|
9.2 KB |
|
| |
SAN MATEO, Calif., Dec 05, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced that on Thursday, December 13, 2007, it will report its September 30, 2007 first quarter fiscal year 2008 financial results. The Company will issue the earnings press release after the NASDAQ Global Market closes and will...
|
|
BioForm Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option
Nov 14, 2007
|
9.0 KB |
|
| |
SAN MATEO, Calif., Nov 14, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced that on November 13, 2007, it closed its previously announced initial public offering of 10,000,000 shares and that the underwriters of the offering exercised their over-allotment option in full and purchased 1,500,000 ad...
|
|
BioForm Announces Pricing of Initial Public Offering
Nov 7, 2007
|
9.2 KB |
|
| |
SAN MATEO, Calif., Nov 07, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced the initial public offering of 10,000,000 shares of common stock at a price of $8.00 per share. BioForm has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares at the initial pu...
|
| |
BioForm Medical Licenses U.S. Rights to Leading European Varicose Vein Treatment
Aug 9, 2007
|
35.9 KB |
|
| |
BioForm Medical Strengthens Management Team with Three Leading Industry Executives
Jul 3, 2007
|
41.3 KB |
|
| |
BioForm Medical Enrolls First Patient in Clinical Trial of CryoLife’s BioGlue Surgical Adhesive for Use in Cosmetic and Plastic Surgery
Jun 26, 2007
|
167.7 KB |
|
| |
Radiesse® Gains Strong Professional Presence at American Academy of Dermatology 2007 Meeting
Feb 8, 2007
|
26.0 KB |
|
| |
Radiesse® Survey Finds Over 22 Million U.S. Women More Apt to Use a Safe, Longer-Lasting and Affordable Cosmetic Wrinkle Filler
Jan 11, 2007
|
37.7 KB |
|
| |
BioForm Announces FDA Approval of Radiesse® Facial Filler For Two New Aesthetic Applications
Dec 22, 2006
|
56.6 KB |
|
| |
FDA Advisory Panel Recommends Approval of Radiesse® For Two Facial Aesthetic Applications
Aug 24, 2006
|
24.8 KB |
|
|
|
